ZHE DA DIXUN Trademark

Trademark Overview

On Saturday, August 6, 2022, a trademark application was filed for ZHE DA DIXUN with the United States Patent and Trademark Office. The USPTO has given the ZHE DA DIXUN trademark a serial number of 97538530. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Friday, December 13, 2024. This trademark is owned by Hangzhou Zheda Dixun Biological Gene Engineering  Co., Ltd. The ZHE DA DIXUN trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Health assessment services; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical assistance; Medical clinic services; Medical equipment rental; Medical screening; Medical services in the nature of administering vaccines; Medical treatment using cultured cells; Remote monitoring of medical data for medical diagnosis and treatment; Telemedicine services

General Information

Serial Number97538530
Word MarkZHE DA DIXUN
Filing DateSaturday, August 6, 2022
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateFriday, December 13, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 5, 2023

Trademark Statements

Description of MarkThe mark consists of a drawing of a gene strand pattern surrounded by a small circle, four Chinese characters above the pattern, and the stylized English wording "ZHE DA DIXUN" below it, all of which is surrounded by a larger circle.
NOT AVAILABLEThe non-Latin characters in the mark transliterate to "ZHE DA DI XUN" and this means "Zhejiang, Big, Direct, Fast" in English.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Translation of Words in MarkThe English translation of the Chinese characters for "Zhe", "Da", "Di" and "Xun" in the mark is "Zhejiang", "Big", "Direct" and "Fast", respectively. However, the combination of wording has no meaning in English; The wording ZHE DA DIXUN has no meaning in a foreign language.
Goods and ServicesHealth assessment services; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical assistance; Medical clinic services; Medical equipment rental; Medical screening; Medical services in the nature of administering vaccines; Medical treatment using cultured cells; Remote monitoring of medical data for medical diagnosis and treatment; Telemedicine services
NOT AVAILABLEthe non-Latin characters that transliterate to "ZHEJIANG"

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, August 28, 2022
Primary Code044
First Use Anywhere DateMonday, November 14, 2022
First Use In Commerce DateSunday, November 20, 2022

Trademark Owner History

Party NameHangzhou Zheda Dixun Biological Gene Engineering  Co., Ltd
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressHangzhou, Zhejiang 310052
CN
Party NameHangzhou Zheda Dixun Biological Gene Engineering  Co., Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressHangzhou, Zhejiang 310052
CN

Trademark Events

Event DateEvent Description
Wednesday, August 10, 2022NEW APPLICATION ENTERED
Sunday, August 28, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 30, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, May 24, 2023ASSIGNED TO EXAMINER
Friday, May 26, 2023NON-FINAL ACTION WRITTEN
Friday, May 26, 2023NON-FINAL ACTION E-MAILED
Friday, May 26, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 25, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 25, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 25, 2023TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Tuesday, July 25, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 26, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 26, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 27, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 3, 2023EXAMINERS AMENDMENT -WRITTEN
Thursday, August 3, 2023EXAMINERS AMENDMENT E-MAILED
Thursday, August 3, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, August 3, 2023EXAMINER'S AMENDMENT ENTERED
Thursday, August 3, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 16, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 5, 2023PUBLISHED FOR OPPOSITION
Tuesday, September 5, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 31, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, April 11, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 11, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 11, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 11, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, April 11, 2024TEAS STATEMENT OF USE RECEIVED
Thursday, April 11, 2024USE AMENDMENT FILED
Tuesday, April 30, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 30, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 30, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 2, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, May 3, 2024STATEMENT OF USE PROCESSING COMPLETE
Monday, June 10, 2024NON-FINAL ACTION E-MAILED
Monday, June 10, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 10, 2024SU - NON-FINAL ACTION - WRITTEN
Tuesday, September 10, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 18, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 18, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 18, 2024ASSIGNED TO LIE
Sunday, December 1, 2024ASSIGNED TO EXAMINER
Friday, December 13, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, December 13, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Related Keywords

dixun medical services treatment cultured using vaccines administering cells remote diagnosis